Investor Communications
NorthStar Healthcare’s Q3 2024 Results and Business Update Conference Call
Frequently Asked Questions
Updated October 17, 2024
Click here to download the Frequently Asked Questions PDF
Supplemental Financial Reports
Third Quarter Ended 2024 Financial Supplement – 11.08.2024
Second Quarter Ended 2024 Financial Supplement – 8.12.2024
First Quarter Ended 2024 Financial Supplement – 5.09.2024
Year Ended 2023 Financial Supplement – 3.22.2024
Third Quarter 2023 Financial Supplement and Estimated Net Asset Value – 11.14.2023
Second Quarter 2023 Financial Supplement – 08.14.2023
First Quarter 2023 Financial Supplement – 05.10.2023
Click here for previous Supplemental Financial Reports
Shareholder Letters
Response to Comrit Tender Offer – 10.17.2024
June 30, 2024 Estimated Per Share Value – 10.17.2024
Response to West 4 Tender Offer – 08.12.2024
Response to Comrit Tender Offer – 05.01.2024
Response to Comrit Tender Offer – 01.11.2024
June 30, 2023 Estimated Per Share Value – 11.14.2023
Response to Comrit Tender Offer – 03.10.2023
Investor Presentation - Internalization of Management
Investor Presentation NHI Internalization, October 2022